Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06191484 · ClinicalTrials.gov registry record · NA
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
A NA study of Suicide and Bereavement, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 169
- Enrollment target
- 1
- Study location
NCT06191484: Recruiting NA study of Suicide and Bereavement, sponsored by University of Pittsburgh.
NCT06191484 is a NA study of Suicide and Bereavement that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 169 participants, below the 6,988-participant average among 92 other Suicide trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06191484, a NA study of Suicide and Bereavement, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 169 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the RISE study is to examine how the 24-hour rhythm of sleep and social activity relate to mood and suicidal ideation among older adults that recently lost a spouse or life partner.
Primary Outcome
The BSSI is one of the most commonly used clinician-administered scales to assess presence and severity of suicidality. The total BSS score can range from 0 to 38, with higher values indicating a greater risk of suicide.
Conditions Studied
Interventions
- BEHAVIORAL WELL Behavioral Probe
Study Locations (1)
Pennsylvania
- University of Pittsburgh (UPMC) - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2023-11-20 |
| Est. Completion | 2029-12-01 |
| Phase | NA |
What NCT06191484 shows while recruiting
NCT06191484 is an interventional study that assigns participants to a tested intervention. The registered 169 participants enrollment target is mid-sized for trials with a published cap, below the 6,988-participant average among 92 other Suicide trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which WELL Behavioral Probe is the first listed.
NCT06191484 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06191484 about?
NCT06191484 is a clinical study titled "Risk and Resilience to Suicide Following Late-Life Spousal Bereavement". The purpose of the RISE study is to examine how the 24-hour rhythm of sleep and social activity relate to mood and suicidal ideation among older adults that recently lost a spouse or life partner.
What is the current status of trial NCT06191484?
This trial is currently recruiting. It is a NA study. The enrollment target is 169 participants. The study started on 2023-11-20. Estimated completion is 2029-12-01.
What conditions does trial NCT06191484 study?
This clinical trial studies the following conditions: Suicide, Bereavement.
What interventions are being tested in trial NCT06191484?
The interventions under investigation include: WELL Behavioral Probe (BEHAVIORAL).
Who is sponsoring clinical trial NCT06191484?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06191484 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06191484's enrollment target sits among peer trials
169 38th of 92 higher than 55 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI